ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol Looks Into Tolerizing Vaccines,
ScripJason Gardner is just a month into his role as CEO of Ampersand Biomedicines , one of the latest companies to emerge from Flagship Pioneering , but is nevertheless confident it can deliver a “new pa
ScripAmylyx Hopes Sunnybrook Might Discover New Methods For Fighting ALS Although it is in the midst of a protracted effort to obtain US Food and Drug Administration approval for its investigational mitoch
ScripBristol, Evotec Tap Researchers In Birmingham, Edinburgh, Nottingham, Dundee Evotec SE and Bristol Myers Squibb Company will collaborate with researchers at four UK universities on identifying pot